| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
SYK
Stryker
|
Oct 30, 2026 | BUY |
Strong Buy
+18.5% avg upside
38 analysts
|
$390.00
33.69% Upside
|
+6.5% | Β· |
|
MBOT
Microbot Medical
|
Oct 23, 2026 | BUY |
Strong Buy
+424.2% avg upside
9 analysts
|
$2.50
129.29% Upside
|
+1.0% | Β· |
|
IART
Integra Lifesciences
|
Oct 22, 2026 | BUY |
Buy
+208.0% avg upside
22 analysts
|
$22.00
72.45% Upside
|
+9.9% | Β· |
|
ATRC
Atricure
|
Oct 21, 2026 | BUY |
Strong Buy
-13.7% avg upside
15 analysts
|
$68.00
11.07% Upside
|
-4.6% | Β· |
|
STXS
Stereotaxis
|
Aug 27, 2026 | BUY |
Strong Buy
+315.5% avg upside
7 analysts
|
$3.00
247.88% Upside
|
-40.1% | Β· |
|
AORT
Artivion
|
May 08, 2026 | BUY |
Strong Buy
+75.4% avg upside
9 analysts
|
$48.00
112.64% Upside
|
-27.7% | Β· |
|
LMAT
Lemaitre Vascular
|
May 06, 2026 | BUY |
Strong Buy
+21.2% avg upside
16 analysts
|
$127.00
56.99% Upside
|
-30.6% | Β· |
|
STIM
Neuronetics
|
Mar 05, 2025 | BUY |
Strong Buy
+160.4% avg upside
8 analysts
|
$7.00
211.20% Upside
|
-74.0% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.